A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly.
Looking at options history for Eli Lilly (NYSE:LLY) we detected 10 strange trades.
If we consider the specifics of each trade, it is accurate to state that 60% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $214,596 and 5, calls, for a total amount of $1,395,015.
What’s The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $250.0 to $450.0 for Eli Lilly over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly’s options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly’s whale trades within a strike price range from $250.0 to $450.0 in the last 30 days.
Eli Lilly Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| LLY | CALL | SWEEP | BULLISH | 09/15/23 | $450.00 | $967.9K | 1.1K | 437 |
| LLY | CALL | TRADE | BULLISH | 05/19/23 | $250.00 | $181.9K | 1 | 10 |
| LLY | CALL | SWEEP | BULLISH | 05/12/23 | $425.00 | $101.0K | 181 | 107 |
| LLY | CALL | TRADE | NEUTRAL | 07/21/23 | $440.00 | $89.4K | 1.7K | 58 |
| LLY | PUT | SWEEP | BULLISH | 05/19/23 | $435.00 | $67.9K | 91 | 233 |
Where Is Eli Lilly Standing Right Now?
- With a volume of 698,908, the price of LLY is down -0.05% at $432.49.
- RSI indicators hint that the underlying stock may be overbought.
- Next earnings are expected to be released in 91 days.
What The Experts Say On Eli Lilly:
- Morgan Stanley has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $448.
- Credit Suisse has decided to maintain their Outperform rating on Eli Lilly, which currently sits at a price target of $420.
- Credit Suisse has decided to maintain their Outperform rating on Eli Lilly, which currently sits at a price target of $490.
- Guggenheim has decided to maintain their Buy rating on Eli Lilly, which currently sits at a price target of $392.
- JP Morgan has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $430.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.
